+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Emergent BioSolutions, Inc. - logo

Emergent BioSolutions manufactures immunobiotics such as vaccines and immune globulins that assist the body’s immune system. The company’s biodefense segment develops drugs such as BioThrax, a vaccine for the prevention of anthrax, for use against biological agents. Other products in preclinical development include drugs for the treatment of patients exposed to anthrax and botulinum toxin. The company, which was founded in 1998, is based in Rockville, Maryland.

From
From
From
Convalescent Plasma Therapy Market Report 2025 - Product Thumbnail Image

Convalescent Plasma Therapy Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Mid-Size Pharmaceuticals Market Report 2025 - Product Thumbnail Image

Mid-Size Pharmaceuticals Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
CD (Cluster Of Differentiation) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

CD (Cluster Of Differentiation) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 120 Pages
  • Global
From
Pharmaceutical Spray Drying Market (2nd Edition), 2018-2028 - Product Thumbnail Image

Pharmaceutical Spray Drying Market (2nd Edition), 2018-2028

  • Report
  • April 2018
  • 200 Pages
  • Global
From
From
From
CD 3 Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

CD 3 Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
From
Anti-CD3 Antibody - Pipeline Insight, 2025 - Product Thumbnail Image

Anti-CD3 Antibody - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Loading Indicator